Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`PTO Form 1478 (Rev 09/2006)
`
`OMB No. 0651-0009 (Exp 02/28/2021)
`
`Trademark/Service Mark Application, Principal Register
`
`Serial Number: 88093870
`Filing Date: 08/27/2018
`
`The table below presents the data as entered.
`
`Input Field
`
`Entered
`
`SERIAL NUMBER
`
`MARK INFORMATION
`
`*MARK
`
`STANDARD CHARACTERS
`
`USPTO-GENERATED IMAGE
`
`LITERAL ELEMENT
`
`MARK STATEMENT
`
`REGISTER
`
`APPLICANT INFORMATION
`
`*OWNER OF MARK
`
`*STREET
`
`*CITY
`
`*COUNTRY
`
`*ZIP/POSTAL CODE
`(Required for U.S. and certain international addresses)
`
`LEGAL ENTITY INFORMATION
`
`88093870
`
`ceDNA
`
`YES
`
`YES
`
`ceDNA
`
`The mark consists of standard characters, without claim to any
`particular font style, size, or color.
`
`Principal
`
`Touchlight IP Limited
`
`40 Queen Anne Street
`
`London
`
`United Kingdom
`
`W1G9EL
`
`TYPE
`
`private limited company
`
`STATE/COUNTRY WHERE LEGALLY ORGANIZED
`
`United Kingdom
`
`GOODS AND/OR SERVICES AND BASIS INFORMATION
`
`INTERNATIONAL CLASS
`
`001 
`
`Chemical preparations, enzymes and DNA for the preparation
`of nucleic acid for scientific research; chemicals for use in the
`preparation and creation of DNA extracts and cassettes for
`scientific and industrial purposes; enzymes for use in the
`preparation and creation of DNA extracts and cassettes for
`scientific and industrial purposes; DNA extracts and cassettes
`for scientific and research use; DNA extracts for use in agri-
`biotechnology and nanotechnology; nucleic acids comprising
`natural and unnatural nucleotides for use in nanotechnology
`applications including data storage, data retrieval and
`computing; nucleic acid analogues comprising synthetic
`backbones or a mixture of natural and synthetic backbones for
`use in nanotechnology applications including data storage, data
`retrieval and computing; composites of nucleic acids or nucleic
`acid analogues with organic and inorganic chemicals for use in
`
`*IDENTIFICATION
`
`

`

`FILING BASIS
`
`FILING BASIS
`
`       FOREIGN APPLICATION NUMBER
`
`       FOREIGN APPLICATION
`       COUNTRY
`
`       FOREIGN FILING DATE
`
`       INTENT TO
`       PERFECT 44(d)
`
`nanotechnology applications including data storage, data
`retrieval and computing; nucleic acid analogues with organic
`and inorganic chemicals for laboratory use in labeling, imaging
`and sensing applications; nucleic acid analogues with organic
`and inorganic chemicals for laboratory use in smart materials;
`two-dimensional and three-dimensional nucleic acid analogues
`with organic and inorganic chemicals for laboratory use in
`creating nanostructures and scaffolds
`
`SECTION 1(b)
`
`SECTION 44(d)
`
`017866519
`
`European Union Trademark - EUTM
`
`02/28/2018
`
`At this time, the applicant intends to rely on Section 44(e) as a
`basis for registration and requests that the application be
`suspended to await the submission of the foreign registration.
`If ultimately the applicant does not rely on §44(e) as a basis for
`registration, a valid claim of priority may be retained.
`
`INTERNATIONAL CLASS
`
`005 
`
`Vaccines; DNA based vaccines; DNA extracts, namely, nucleic
`acid sequences and chemical reagents for medical use;
`therapeutic DNA, namely, nucleic acid sequences and chemical
`reagents for medical and veterinary purposes; nucleic acids
`comprising natural and unnatural nucleotides for medical and
`veterinary purposes; nucleic acid analogues comprising
`synthetic backbones or a mixture of natural and synthetic
`backbones for medical and veterinary purposes; composites of
`nucleic acids or nucleic acid analogues with organic and
`inorganic chemicals for medical and veterinary purposes;
`nucleic acid analogues with organic and inorganic chemicals
`for medical and veterinary purposes in labeling, imaging and
`sensing applications; nucleic acid analogues with organic and
`inorganic chemicals for medical and veterinary purposes in
`smart materials; two-dimensional and three-dimensional
`nucleic acid analogues with organic and inorganic chemicals
`for medical and veterinary purposes in creating nanostructures
`and scaffolds
`
`SECTION 1(b)
`
`SECTION 44(d)
`
`017866519
`
`European Union Trademark - EUTM
`
`02/28/2018
`
`At this time, the applicant intends to rely on Section 44(e) as a
`basis for registration and requests that the application be
`suspended to await the submission of the foreign registration.
`If ultimately the applicant does not rely on §44(e) as a basis for
`registration, a valid claim of priority may be retained.
`
`Mark Harrison
`
`*IDENTIFICATION
`
`FILING BASIS
`
`FILING BASIS
`
`       FOREIGN APPLICATION NUMBER
`
`       FOREIGN APPLICATION
`       COUNTRY
`
`       FOREIGN FILING DATE
`
`       INTENT TO
`       PERFECT 44(d)
`
`ATTORNEY INFORMATION
`
`NAME
`
`

`

`ATTORNEY DOCKET NUMBER
`
`FIRM NAME
`
`STREET
`
`CITY
`
`STATE
`
`COUNTRY
`
`ZIP/POSTAL CODE
`
`PHONE
`
`EMAIL ADDRESS
`
`60895-435595
`
`Venable LLP
`
`P.O. Box 34385
`
`Washington
`
`District of Columbia
`
`United States
`
`20043-9998
`
`202-344-4019
`
`mbharrison@venable.com
`
`AUTHORIZED TO COMMUNICATE VIA EMAIL
`
`Yes
`
`OTHER APPOINTED ATTORNEY
`
`Rebecca Liebowitz, Catherine Mitros
`
`DOMESTIC REPRESENTATIVE INFORMATION
`
`NAME
`
`FIRM NAME
`
`STREET
`
`CITY
`
`STATE
`
`COUNTRY
`
`ZIP CODE
`
`PHONE
`
`Mark Harrison
`
`Venable LLP
`
`P.O. Box 34385
`
`Washington
`
`District of Columbia
`
`United States
`
`20043-9998
`
`202-344-4019
`
`EMAIL ADDRESS
`
`mbharrison@venable.com
`
`AUTHORIZED TO COMMUNICATE VIA EMAIL
`
`Yes
`
`CORRESPONDENCE INFORMATION
`
`NAME
`
`FIRM NAME
`
`STREET
`
`CITY
`
`STATE
`
`COUNTRY
`
`ZIP/POSTAL CODE
`
`PHONE
`
`*EMAIL ADDRESS
`
`Mark Harrison
`
`Venable LLP
`
`P.O. Box 34385
`
`Washington
`
`District of Columbia
`
`United States
`
`20043-9998
`
`202-344-4019
`
`mbharrison@venable.com; trademarkdocket@venable.com
`
`*AUTHORIZED TO COMMUNICATE VIA EMAIL
`
`Yes
`
`FEE INFORMATION
`
`APPLICATION FILING OPTION
`
`NUMBER OF CLASSES
`
`APPLICATION FOR REGISTRATION PER CLASS
`
`*TOTAL FEE DUE
`
`TEAS RF
`
`2
`
`275
`
`550
`
`

`

`
`
`*TOTAL FEE PAID
`
`
`
`SIGNATURE INFORMATION
`
`550
`
`
`
`| SIGNATURE
`NOT PROVIDED
`
`‘ SIGNATORY'S NAME
`NOT PROVIDED
`SIGNATORY'S POSITION
`NOT PROVIDED
`
`I DATE SIGNED
`
`NOT PROVIDED
`
`
`
`*TOTAL FEE PAID
`
`SIGNATURE INFORMATION
`
`SIGNATURE
`
`SIGNATORY'S NAME
`
`SIGNATORY'S POSITION
`
`DATE SIGNED
`
`550
`
`NOT PROVIDED
`
`NOT PROVIDED
`
`NOT PROVIDED
`
`NOT PROVIDED
`
`

`

`Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`PTO Form 1478 (Rev 09/2006)
`
`OMB No. 0651-0009 (Exp 02/28/2021)
`
`Trademark/Service Mark Application, Principal Register
`
`Serial Number: 88093870
`Filing Date: 08/27/2018
`
`To the Commissioner for Trademarks:
`
`MARK: ceDNA (Standard Characters, see mark)
`The literal element of the mark consists of ceDNA.
`The mark consists of standard characters, without claim to any particular font style, size, or color.
`
`The applicant, Touchlight IP Limited, a private limited company legally organized under the laws of United Kingdom, having an address of
`      40 Queen Anne Street
`      London W1G9EL
`      United Kingdom
`
`requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register
`established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:
`
`       International Class 001:  Chemical preparations, enzymes and DNA for the preparation of nucleic acid for scientific research; chemicals for
`use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; enzymes for use in the preparation and
`creation of DNA extracts and cassettes for scientific and industrial purposes; DNA extracts and cassettes for scientific and research use; DNA
`extracts for use in agri-biotechnology and nanotechnology; nucleic acids comprising natural and unnatural nucleotides for use in nanotechnology
`applications including data storage, data retrieval and computing; nucleic acid analogues comprising synthetic backbones or a mixture of natural
`and synthetic backbones for use in nanotechnology applications including data storage, data retrieval and computing; composites of nucleic acids
`or nucleic acid analogues with organic and inorganic chemicals for use in nanotechnology applications including data storage, data retrieval and
`computing; nucleic acid analogues with organic and inorganic chemicals for laboratory use in labeling, imaging and sensing applications; nucleic
`acid analogues with organic and inorganic chemicals for laboratory use in smart materials; two-dimensional and three-dimensional nucleic acid
`analogues with organic and inorganic chemicals for laboratory use in creating nanostructures and scaffolds
`Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified
`goods/services.
`
`Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the
`identified goods/services and asserts a claim of priority based on European Union Trademark - EUTM application number 017866519, filed
`02/28/2018.
`INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the
`application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for
`registration, a valid claim of priority may be retained.
`
`       International Class 005:  Vaccines; DNA based vaccines; DNA extracts, namely, nucleic acid sequences and chemical reagents for medical
`use; therapeutic DNA, namely, nucleic acid sequences and chemical reagents for medical and veterinary purposes; nucleic acids comprising
`natural and unnatural nucleotides for medical and veterinary purposes; nucleic acid analogues comprising synthetic backbones or a mixture of
`natural and synthetic backbones for medical and veterinary purposes; composites of nucleic acids or nucleic acid analogues with organic and
`inorganic chemicals for medical and veterinary purposes; nucleic acid analogues with organic and inorganic chemicals for medical and veterinary
`purposes in labeling, imaging and sensing applications; nucleic acid analogues with organic and inorganic chemicals for medical and veterinary
`purposes in smart materials; two-dimensional and three-dimensional nucleic acid analogues with organic and inorganic chemicals for medical
`and veterinary purposes in creating nanostructures and scaffolds
`Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified
`goods/services.
`
`Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the
`identified goods/services and asserts a claim of priority based on European Union Trademark - EUTM application number 017866519, filed
`02/28/2018.
`INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the
`application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for
`
` 
`

`

`registration, a valid claim of priority may be retained.
`
`The applicant's current Attorney Information:
`      Mark Harrison and Rebecca Liebowitz, Catherine Mitros of Venable LLP      P.O. Box 34385
`      Washington, District of Columbia 20043-9998
`      United States
`      202-344-4019(phone)
`      mbharrison@venable.com (authorized)
`The attorney docket/reference number is 60895-435595.
`
`The applicant hereby appoints Mark Harrison of Venable LLP
`      P.O. Box 34385
`      Washington District of Columbia 20043-9998
`      United States
`      202-344-4019(phone)
`      mbharrison@venable.com (authorized)
`as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.
`
`The applicant's current Correspondence Information:
`      Mark Harrison
`      Venable LLP
`      P.O. Box 34385
`      Washington, District of Columbia 20043-9998
`      202-344-4019(phone)
`      mbharrison@venable.com;trademarkdocket@venable.com (authorized)
`E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's
`attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address
`must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the
`Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to
`submit an additional processing fee of $125 per international class of goods/services.
`
`A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).
`
`Declaration
`
`Basis:
`If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a):
`
`The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered;
`The mark is in use in commerce on or in connection with the goods/services in the application;
`The specimen(s) shows the mark as used on or in connection with the goods/services in the application; and
`To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
`
`And/Or
`If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d),
`and/or § 1126(e):
`
`The signatory believes that the applicant is entitled to use the mark in commerce;
`The applicant has a bona fide intention to use the mark in commerce on or in connection with the goods/services in the
`application; and
`To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
`
`To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the
`mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the
`goods/services of such other persons, to cause confusion or mistake, or to deceive.
`
`To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the
`allegations and other factual contentions made above have evidentiary support.
`
`

`

`The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §
`1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration
`resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and
`belief are believed to be true.
`Declaration Signature
`
`Signature: Not Provided    Date: Not Provided
`Signatory's Name: Not Provided
`Signatory's Position: Not Provided
`Payment Sale Number: 88093870
`Payment Accounting Date: 08/27/2018
`
`Serial Number: 88093870
`Internet Transmission Date: Mon Aug 27 13:31:54 EDT 2018
`TEAS Stamp: USPTO/BAS-XXX.XX.XXX.XXX-201808271331547
`93583-88093870-6107fb9c32b48455e8b67f2a7
`f33f986d9d177a9888da6ddabb429c4c6ebc8a2b
`1-DA-11646-20180827131337742714
`
` 
`

`

`ceDNA
`
`